Skip to main content

Table 1 Characteristics of the study population (N = 21,803), by age groups

From: Urinary incontinence associated with anxiety and depression: the impact of psychotropic drugs in a cross-sectional study from the Norwegian HUNT study

Age at inclusion (years)
Number of women (N)
19–39
N = 4916
40–54
N = 6726
≥55
N = 10,161
All
N = 21,803
N % N % N % N %
Parity a
 None 1577 32.1 402 6.0 643 6.3 2622 12.0
 1 712 14.5 645 9.6 733 7.2 2090 9.6
 2 1565 31.8 2770 41.2 3296 32.4 7631 35.0
  ≥ 3 1050 21.4 2895 43.0 5472 53.9 9417 43.2
Body mass index a
  < 18.5 (underweight) 72 1.5 40 0.6 70 0.7 182 0.8
 18.5–24.9 (normal) 2515 51.2 2707 40.2 2991 29.4 8213 37.8
 25.0–29.9 (overweight) 1434 29.2 2579 38.3 4245 41.8 8258 38.0
  ≥ 30 (obesity) 879 17.9 1387 20.6 2806 27.6 5072 23.3
Asthma 668 13.6 752 11.2 1211 11.9 2631 12.1
Myocardial infarction 1 0 24 0.4 312 3.1 337 1.5
Cerebral stroke 11 0.2 72 1.1 424 4.2 507 2.3
Diabetes 47 1.0 137 2.0 672 6.6 856 3.9
Continence status a
 Continent 3800 77.3 4735 70.4 6936 68.3 15,471 71.0
 Any UI 1116 22.7 1991 29.6 3225 31.7 6332 29.0
Type of UI (n = 6332) a
 Stress 613 54.9 1015 50.9 1068 33.2 2696 42.6
 Urgency 136 12.2 213 10.7 524 16.2 873 13.8
 Mixed 296 26.5 705 35.4 1471 45.6 2472 39.0
 Other/unclassified 68 6.1 51 2.6 132 4.1 251 4.0
 Missing 3 0.3 7 0.4 30 0.9 40 0.6
Severity of UI (n = 6332) a
 Slight 664 59.5 959 48.2 952 29.5 2575 40.7
 Moderate 398 35.7 888 44.6 1498 46.4 2784 44.0
 Severe 33 3.0 89 4.5 522 16.2 644 10.2
 Very severe 1 0.1 14 0.7 101 3.1 116 1,8
 Missing 20 1.8 41 2.1 152 4.7 213 3.4
Anxiety
HADS-A 8–10.9 569 11.6 714 10.6 1106 10.9 2389 11.0
  Antidepressant status (n = 2389) a
   Using 62 10.9 114 16.0 211 19.1 387 16.2
   Not using 507 89.1 600 84.0 895 80.9 2002 83.8
HADS-A ≥ 11 311 6.3 442 6.6 563 5.5 1316 6.0
  Antidepressant status (n = 1316) a
   Using 62 19.9 130 29.4 197 35.0 389 29.6
   Not using 249 80.1 312 70.6 366 65.0 927 70.4
Depression
HADS-D 8–10.9 215 4.4 377 5.6 839 8.3 1431 6.6
  Antidepressant status (n = 1431) a
   Using 32 14.9 94 24.9 178 21.2 304 21.2
   Not using 183 85.1 283 75.1 661 78.8 1127 78.8
HADS-D ≥ 11 60 1.2 146 2.2 240 2.4 446 2.0
  Antidepressant status (n = 446)) a
   Using 21 35.0 49 33.6 85 35.4 155 34.8
   Not using 39 65.0 97 66.4 155 64.6 291 65.2
Psychotropic drug use b
 Opioid analgesics 245 5.0 540 8.0 912 9.0 1697 7.8
 Non-opioid analgesics 136 2.8 385 5.7 891 8.8 1412 6.5
 Anti-epileptics 47 1.0 133 2.0 213 2.1 393 1.8
 Lamotrigin 21 0.4 26 0.4 35 0.3 82 0.4
 Anti-parkinson drug 1 0 7 0.1 87 0.9 95 0.4
 Anti-psychotics 34 0.7 107 1.6 238 2.3 379 1.7
 Anxiolytics 72 1.5 283 4.2 817 8.0 1172 5.4
 Hypnotics/sedatives 91 1.9 391 5.8 1693 16.7 2175 10.0
 Anti-depressants (all) 234 4.8 588 8.7 1125 11.1 1947 8.9
 SSRI 163 3.3 358 5.3 653 6.4 1174 5.4
  1. UI Urinary incontinence
  2. HADS Hospital anxiety and depression scale
  3. SSRI selective serotonin receptor inhibitor
  4. aColumn-distribution
  5. b Drug use was defined as dispensed prescription last 6 months